David N. Gordon

David N. Gordon, listed as senior executive, appears in our data through filings on Aclaris Therapeutics, Inc. shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 1 June 2021 and the latest from 13 July 2021.

Every open-market trade on record is a sale: 1 sale worth €38k. Outside the open market, there are 2 option exercises.

Most recently, on 14 July 2021, the filings show an open-market sale worth €38k in Aclaris Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.